neoLaser
neoLaser is an Israeli medical device company that designs, manufactures, and distributes surgical diode laser systems and proprietary fiber consumables (neoV platform) for endovenous, proctology, spine, podiatry, and aesthetic procedures, serving hospitals and clinics across 50+ countries.
- Company typePrivate
- Founded2012
- HeadquartersCaesarea, Israel
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What neoLaser does
neoLaser (legal name G.N.S. neoLaser Ltd.) is an Israeli medical device company founded in 2012 in Caesarea that designs, manufactures, and distributes surgical diode laser systems and proprietary fiber/probe consumables. Its flagship neoV platform comprises four wavelength-specific laser systems — neoV1940, neoV1470, neoV1064, and neoV980 — optimized for distinct clinical applications including endovenous laser ablation (EVLA), proctology (hemorrhoids, fistula, pilonidal sinus), percutaneous laser disc decompression (PLDD), podiatry, and aesthetic vascular procedures. The company's core technical differentiation is its proprietary CORONA fiber technology family (including CORONA 360, CORONA Infinite Ring, and RIGID probes), which uses patented multi-ring cylindrical emission patterns and fused quartz tips to deliver precise thermal energy with reduced collateral damage. The systems are marketed as the world's smallest high-power surgical lasers due to proprietary cooling technology.
neoLaser generates revenue through two primary streams: (1) capital equipment sales of neoV laser systems, and (2) recurring sales of proprietary fiber and probe consumables designed exclusively for neoV hardware. Pricing is quote-based and not publicly disclosed, with sales executed exclusively through a global network of authorized distributors and dealers. The company holds EN ISO13485:2021 certification and regulatory registrations across FDA (USA), CE Mark (Europe), Canada, Brazil, Australia, Israel, and Taiwan. With 2,300+ systems placed across 50+ countries and 500,000+ procedures performed, neoLaser serves hospitals, surgical centers, and clinics across vascular surgery, colorectal surgery, spine surgery, podiatry, and aesthetic specialties. In August 2024, the company was acquired by investment firm Afinum 9 as part of the formation of the MedTech Laser Group alongside A.R.C. Laser GmbH, with the founders of both companies co-investing; neoLaser continues to operate independently while leveraging combined R&D, sales, marketing, and regulatory capabilities within the group.
neoLaser firmographics
Firmographics- Name
- neoLaser
- Legal name
- G.N.S neoLaser Ltd.
- Website
- https://neo-laser.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- neoLaser is an Israeli medical device company that designs, manufactures, and distributes surgical diode laser systems and proprietary fiber consumables (neoV platform) for endovenous, proctology, spine, podiatry, and aesthetic procedures, serving hospitals and clinics across 50+ countries.
- Ownership category
- akta.pro rank
neoLaser industry classification
Industry- Product category
- Surgical Laser Systems
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser) (HLAHADAC)
- akta.pro secondary industry
- Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM)
Keywords
Where neoLaser is headquartered
LocationHeadquarters
- HQ city
- Caesarea
- HQ country
- Israel
- HQ region
- Middle East
Offices1 record
Markets served
neoLaser business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations
Revenue model
- Surgical Laser Systems Sales: neoLaser designs, engineers, and manufactures surgical laser systems and proprietary fiber/probe technology. Revenue is generated through the sale of laser hardware systems (neoV1940, neoV1470, neoV1064, neoV980) along with compatible fiber and probe accessories.
- Consumables and Accessories: Sale of proprietary fiber products including CORONA Infinite Ring Fibers, CORONA 360 Fibers, hemorrhoid probes, fistula probes, and procedure kits (PLDD Kit, EVLA Introducer Kit, Hemorrhoid Cannula, Focusing Hand Pieces).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Quote-based pricing through distributor network |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels3 records
neoLaser product offering
Product offeringCore offering
neoLaser designs, engineers, and manufactures surgical diode laser systems and proprietary fiber/probe accessories for minimally invasive medical procedures. Its flagship neoV platform encompasses four wavelength-specific laser systems (neoV1940, neoV1470, neoV1064, neoV980) used for endovenous laser ablation (EVLA), proctology (hemorrhoids, fistula, pilonidal sinus), percutaneous laser disc decompression (PLDD), podiatry, and aesthetic vascular treatments. The company sells these systems and consumable CORONA fiber/probe products to hospitals, surgical centers, and clinics through a global distributor network.
Product overview
neoLaser is a surgical laser manufacturer offering the neoV platform as its core product line, comprising four distinct laser systems (neoV1940, neoV1470, neoV1064, and neoV980) designed for different medical specialties including EVLA (endovenous laser ablation), proctology, PLDD (percutaneous laser disc decompression), and podiatry. The platform is complemented by an extensive portfolio of proprietary CORONA fiber and probe products featuring proprietary multiple ring emission technology, including EVLA fibers (Infinite Ring Fiber, CORONA 360 Slim Fiber), hemorrhoid probes (RIGID Infinite Ring, CORONA Infinite Ring, CORONA Hemorrhoid), and fistula probes (Infinite Ring Fistula, CORONA Fistula). Supporting accessories include PLDD kits, EVLA introducer kits, hemorrhoid cannulas, and focusing hand pieces. All products are designed, engineered, and manufactured with EN ISO13485:2021 certification and are registered with regulatory bodies including FDA, CE Mark, Canada, Brazil, Australia, Israel, Taiwan, and more.
Differentiator
Problem solved
Functional benefit
Brands
- neoV Platform: Surgical laser platform family including neoV1940, neoV1470, neoV1064, and neoV980 laser systems for EVLA, proctology, PLDD, and aesthetic procedures.
- CORONA Fiber Technology
- MedTech Laser Group
Products and services
- neoV1940 Laser System Next generation 1940nm surgical diode laser system representing the most advanced platform for endovenous laser ablation (EVLA), providing penetration depth below 1mm for contained thermal damage within the vein wall, preventing collateral damage while maintaining long-term closure rates. Targeted at vascular surgeons and hospitals performing minimally invasive vein treatment.
- neoV1470 Laser System Workhorse 1470nm surgical diode laser platform representing the large majority of the installed base. Microsurgical instrument for endovenous laser ablation of veins and key indications in proctology and PLDD, with peak water absorption at 1470nm enabling precise cutting with good coagulation of soft tissue.
- neoV1064 Laser System
Quantifiable outcome
- Higher closure rates vs RFA for both truncal and perforator veins (KR. Woodburn, 2020)
- +13 more outcomes
Companies that use neoLaser
Customer profileNamed customers1 record
Segments5 records
Ideal customer profiles4 records
neoLaser technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
neoLaser partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- A.R.C. Laser GmbHcoreGerman laser company that was acquired alongside neoLaser as part of the MedTech Laser Group formation. The two companies will operate independently while leveraging combined R&D, sales, marketing, and regulatory capabilities, capitalizing on growth trends in the global ophthalmologic and surgical laser market.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
neoLaser competitors and assessment
Company assessmentMarket position
Strengths4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
neoLaser social profiles
Digital presenceneoLaser compliance and trust
Trust signalCompliance4 records
neoLaser financial estimates
Financial estimateRevenue estimate
Valuation estimate
neoLaser leadership team
Management profileNumber of profiles
Profiles6 records
neoLaser funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
neoLaser M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about neoLaser
What does neoLaser do?
neoLaser designs, engineers, and manufactures surgical diode laser systems and proprietary fiber/probe accessories for minimally invasive medical procedures. Its flagship neoV platform encompasses four wavelength-specific laser systems (neoV1940, neoV1470, neoV1064, neoV980) used for endovenous laser ablation (EVLA), proctology (hemorrhoids, fistula, pilonidal sinus), percutaneous laser disc decompression (PLDD), podiatry, and aesthetic vascular treatments. The company sells these systems and consumable CORONA fiber/probe products to hospitals, surgical centers, and clinics through a global distributor network.
Is neoLaser a public or private company?
neoLaser is a private company. It is classified as private equity controlled and is currently operating.
When was neoLaser founded?
neoLaser was founded in 2012. It employs 1 to 10 people.
Where is neoLaser based?
neoLaser is headquartered in Caesarea, Israel, in the Middle East region.
How does neoLaser make money?
Two revenue lines are on record. Surgical Laser Systems Sales are the primary driver. The others are consumables and Accessories.
Does neoLaser have an API?
No public API is recorded for neoLaser.
What industry is neoLaser in?
neoLaser's product category is Surgical Laser Systems. Its primary akta.pro industry code is HLAHADAC, Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser), with a secondary code of HLAHADAM, Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits). Its NAICS code is 339112 and its SIC code is 3841.